The Relationship between Rheumatoid Arthritis
and Heart Failure
Post Test

A score of 70% must be achieved to receive continuing education credits.
 
1. Which of the following medications for treating RA is a tumor necrosis factor inhibitor?
 a. Cyclophosphamide
 b. Methotrexate
 c. Etanercept
 d. Anakinra
2. Which of the following are patients with RA at risk for compared with patients without RA?
 a. Myocardial infarction
 b. Atherosclerosis
 c. Heart Failure
 d. All of the above
3. Cardiovascular disease accounts for nearly 50 percent of mortality among patients with RA.
   True
   False
4. Which of the following is a likely explanation for the increased risk of heart failure among patients with RA?
  a. Elevation of blood pressure by tumor necrosis factor inhibitors
  b. Underlying pathophysiology of RA resulting in left ventricular diastolic dysfunction
 c. Underlying pathophysiology of RA resulting in mitral valve prolapse
d. Elevation of blood glucose and subsequent development of type 2 diabetes secondary to methotrexate
5. Patients with RA are less likely to present with classic symptoms of heart failure.
 True
 False
6. Which of the following is a correct statement regarding tumor necrosis factor inhibitors?
  a. Early use of these agents has been shown to increase risk of stroke.
  b. They are contraindicated in all forms of heart failure.
 c. Although controversial, they may increase their risk of new-onset heart failure and exacerbate pre-existing heart failure.
 d. These agents increase the levels of TNF in the blood that reduces inflammation.
7. Which of the following is a FALSE statement?
  a. The median life expectancy of persons with RA is shortened by 3–7 years.
  b. Cardiovascular disease related to RA can manifest before the diagnosis of RA.
 c. Statins and angiotension converting enzyme inhibitors have been shown to reduce markers of inflammation.
 d. C reactive protein (CRP) status can be used to discriminate between two groups of RA subjects at different risks of heart failure.
8. Control of inflammation with tumor necrosis factor inhibitors appears to reduce risk of cardiovascular disease.
 True
 False
9. Corticosteroids and NSAIDs used in the treatment of RA do not contribute to excess cardiovascular risk in patients with RA.
  True
   False
10. Which of the following is a contributor to endothelial dysfunction in patients with RA?
  a. Pro-oxidative dyslipidemia
 b. Insulin resistance
 c. Immune mechanisms such as t-cell activation
 d. All of the above

 

Activity Evaluation

Please rate this activity on the following scale:
4 - Excellent        3 - Good        2 - Fair        1 - Poor
1.Based on the content presented I am better able to:  
  • Identify the current treatment options available for rheumatoid arthritis patients
    4        3        2        1
  • Identify the cardiovascular disease that patients with rheumatoid arthritis are at higher risk for than the general population
    4        3        2        1
  • Discuss the contributors to cardiovascular disease morbidity and mortality found in patients with rheumatoid arthritis
   4        3        2        1
  • Describe the variations in clinical presentation of heart failure between patients with RA and those without the disease
   4        3        2        1
2. Activity met my expectations    4        3        2        1  
3. Activity was free of bias    4        3        2        1
4. Activity content was understandable    4        3        2        1
5. Presenter was free of bias    4        3        2        1
6. Method of learning was beneficial    4        3        2        1
7. Presenter covered material to extent expected    4        3        2        1


Due to the content of this activity, I will change my practice patterns by:

Providing appropriate education to patients
Be aware of the challenges of managing RA patients
My practice patterns will not change
Other    Specify:

Continuing education implies quality improvement in behavior. As part of our quality improvement process, NAMCP/AAMCN will contact you 6 months from your post test submission to monitor change.
Name:  
Profession: MD  DO  RN  LPN  Other
Company:  
Mailing Address:  
City, State, Zip:  
Phone:  
Fax:  
Email:  
Heard About Activity By: eNews  Colleague  Internet    JMCM Article
 Email   Phone
 
Send my certificate by: U.S. Mail             Email
 

Help us cut down spam.

Type the number 411 into
the following box (Required)